[ACRX] YoY Quarter Result on 30-Jun-2015 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
03-Aug-2015
Financial Year
2015
Quarter
30-Jun-2015 [#Q2]
Profit Trend
QoQ- 11.27%
YoY- 15.88%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
Revenue 818 2,659 4,531 1,924 71 407 224 24.08%
PBT -10,539 -13,057 -11,092 -8,896 -10,575 -17,447 -6,596 8.11%
Tax 2 2 -2,083 777 2,215 -9,273 248 -55.20%
NP -10,541 -13,059 -11,092 -8,896 -10,575 -17,447 -7,194 6.57%
Tax Rate - - - - - - - -
Total Cost 11,359 15,718 15,623 10,820 10,646 17,854 7,418 7.35%
Ratio Analysis
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
NP Margin -1,288.63 -491.12 -244.80 -462.37 -14,894.37 -4,286.73 -3,211.61 -14.11%
Per Share
30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 CAGR
EPS -4.07 -5.76 -4.90 -4.01 -4.88 -9.36 -6.98 -8.59%
EPS Diluted -4.07 -5.76 -4.90 -4.01 -4.77 -9.36 -6.98 -8.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.